Italy unveils Covid vaccination plan, 202 mn doses to be given early 2021

Italy's national Covid-19 vaccination campaign will see the first tranche of 202 million doses to be distributed to some 40 million people in the first quarter of 2021

Covid-19 coronavirus
Representative photo of a vaccine
IANS Rome
2 min read Last Updated : Dec 03 2020 | 7:38 AM IST

Italy's national Covid-19 vaccination campaign will see the first tranche of 202 million doses to be distributed to some 40 million people in the first quarter of 2021, Health Minister Roberto Speranza stated on Wednesday.

Unveiling the plan before the parliament, Speranza explained that the vaccine would be free and voluntary, Xinhua news agency reported.

"Our goal is to start with no obligation, but (instead) with persuasion and information in order to reach the herd immunity with about 40 million Italians," he told lawmakers.

According to the minister, the first doses of the Pfizer vaccine will be delivered to Italy between January 23 and January 26, and "will be stored in 300 points within public hospitals".

The campaign will start with health care workers and staff, and residents in nursing homes, before moving to vulnerable groups such as the elders -- first the over-80s and then those between 60 and 80 years. The next group will be workers employed in essential sectors, including schools.

The Italian army will be directly involved in the distribution of the vaccine. "This is especially true for those (vaccine doses) requiring a standard cold chain," Speranza said, adding that the army is now planning carriers, modalities and logistics with Domenico Arcuri, the special commissioner for coronavirus emergency.

The campaign will be managed at a central level in the first phase, with a task force identifying all the specific hospitals and facilities where the vaccine will be administered across the country. Mobile health units will be deployed in order to reach the people who are physically impeded to reach the vaccination points.

--IANS

int/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusItalyCoronavirus VaccineCoronavirus TestsHealth crisis

First Published: Dec 03 2020 | 7:12 AM IST

Next Story